title: The bioethics of iPS cell-based drug discovery.
abstract: The ability to generate human induced pluripotent stem (iPS) cells presents exciting prospects for drug discovery and the development of safer, more effective drugs. Given the enormous potential for iPS cell-based drug development, what ethical issues could possibly cloud this new biomedical horizon?
authors.affiliation: Department of Bioethics, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA. insoo.hyun@case.edu
authors.forename: I
authors.initials: I
authors.lastname: Hyun
mesh_terms: D026688:Bioethical Issues; D002454:Cell Differentiation / Q000502:physiology; D055808:Drug Discovery / Q000941:ethics* / Q000639:trends; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology / Q000637:transplantation; D028681:Moral Obligations